SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories ends with a stellar gain of 32% on the BSE

23 Dec 2015 Evaluate

Alkem Laboratories made a stellar debut and snapped the session at Rs 1381.45, a premium of 31.57% or higher by 331.45 points as against its issue price of Rs 1050, on BSE.

The shares of the company debuted at Rs 1380.00 and touched a high and low of Rs 1410.00 and 1355.40 respectively. A total of 24,38,000 shares were traded on the counter.

The issue price of Alkem Laboratories was fixed at Rs 1050 per share i.e. at the higher end of the price band of Rs 1020-1050 apiece. The offering was subscribed 44.29 times.

The objects of the offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of 12,853,442 Equity Shares by the Selling Shareholders.

Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. Alkem Labs produces branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which they market in India and 55 countries internationally, primarily the United States.

Alkem Laboratories Share Price

5596.75 56.70 (1.02%)
07-May-2026 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1842.80
Dr. Reddys Lab 1309.95
Cipla 1374.15
Zydus Lifesciences 941.40
Lupin 2469.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×